Market Cap 10.18B
Revenue (ttm) 2.17B
Net Income (ttm) 521.27M
EPS (ttm) N/A
PE Ratio 21.10
Forward PE 18.16
Profit Margin 24.04%
Debt to Equity Ratio 0.00
Volume 1,855,000
Avg Vol 2,707,452
Day's Range N/A - N/A
Shares Out 279.88M
Stochastic %K 52%
Beta 0.57
Analysts Sell
Price Target $37.15

Latest News on EXEL

Exelixis Growth Continues with Big Money Boosts

Mar 19, 2025, 7:09 AM EDT - 14 days ago

Exelixis Growth Continues with Big Money Boosts


Why Is Cancer-Focused Exelixis Stock Trading Higher On Friday?

Feb 21, 2025, 1:30 PM EST - 5 weeks ago

Why Is Cancer-Focused Exelixis Stock Trading Higher On Friday?


Exelixis, Inc. (EXEL) Q4 2024 Earnings Call Transcript

Feb 11, 2025, 8:24 PM EST - 7 weeks ago

Exelixis, Inc. (EXEL) Q4 2024 Earnings Call Transcript


Revenues, Treatment Pipeline Driving Exelixis Higher

Jan 22, 2025, 7:44 AM EST - 2 months ago

Revenues, Treatment Pipeline Driving Exelixis Higher


Exelixis, Inc. (EXEL) Q3 2024 Earnings Call Transcript

Oct 29, 2024, 10:31 PM EDT - 5 months ago

Exelixis, Inc. (EXEL) Q3 2024 Earnings Call Transcript


3 Attractive Biotechs With Recent Positives

Oct 21, 2024, 4:17 PM EDT - 5 months ago

3 Attractive Biotechs With Recent Positives

FOLD MRK TEVA XBI


Exelixis Earnings Drive Share Growth

Aug 16, 2024, 8:09 AM EDT - 8 months ago

Exelixis Earnings Drive Share Growth


Exelixis: sNDA Cabometyx Expansion Could Provide Revenue Boost

Aug 8, 2024, 4:04 PM EDT - 8 months ago

Exelixis: sNDA Cabometyx Expansion Could Provide Revenue Boost


Exelixis, Inc. (EXEL) Q2 2024 Earnings Call Transcript

Aug 6, 2024, 9:30 PM EDT - 8 months ago

Exelixis, Inc. (EXEL) Q2 2024 Earnings Call Transcript


Exelixis, Inc. (EXEL) Q1 2024 Earnings Call Transcript

Apr 30, 2024, 9:27 PM EDT - 1 year ago

Exelixis, Inc. (EXEL) Q1 2024 Earnings Call Transcript